This content is only available within our institutional offering.

02 Nov 2023
Hikma Pharmaceuticals: 4% upgrades to FY23 and well set into FY24

Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
Hikma Pharmaceuticals: 4% upgrades to FY23 and well set into FY24
Hikma Pharmaceuticals Plc (HIK:LON) | 1,751 -437.8 (-1.4%) | Mkt Cap: 3,885m
- Published:
02 Nov 2023 -
Author:
Paul Cuddon | Kane Slutzkin -
Pages:
4 -